These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 5859903)

  • 21. [Study of hepatic function of patients with pulmonary tuberculosis treated with morphazinamide].
    Stupenengo RH; Martínez M
    Prensa Med Argent; 1966 Aug; 53(33):1808-11. PubMed ID: 5994109
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical observations on morphazinamide administered intravenously in pulmonary tuberculosis].
    Durigato S
    G Ital Chemioter; 1965; 12(1):82-98. PubMed ID: 5881989
    [No Abstract]   [Full Text] [Related]  

  • 23. [Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].
    Irtuganova OA; Smirnova NS; Slogotskaia LV
    Probl Tuberk Bolezn Legk; 2003; (7):40-2. PubMed ID: 12939878
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of chronic destructive pulmonary tuberculosis by intravenous injections of morphazinamide].
    Utkin VV; Zankisova IG; Polishchuk AK; Krylova NP; Gridneva SM
    Vrach Delo; 1972 Feb; 2():57-8. PubMed ID: 5084744
    [No Abstract]   [Full Text] [Related]  

  • 25. [Behavior of some hematochemical data and of the most important biological indexes of disease and of phase in subjects affected by pulmonary tuberculosis treated with morphazinamide].
    Caltagirone S
    Minerva Med; 1965 Sep; 56(70):2766-71. PubMed ID: 5322265
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tuberculosis treatment today].
    Sjögren I; Boman G; Löfdahl CG; Skoogh BE
    Lakartidningen; 1984 Dec; 81(49):4655-9. PubMed ID: 6521569
    [No Abstract]   [Full Text] [Related]  

  • 28. Tuberculostatic activity of N-morpholino-4'-méthylamide pyrazincarbonic acid on experimental tuberculosis in mice.
    Verbist L
    Acta Tuberc Pneumol Belg; 1966; 57(3):211-7. PubMed ID: 5985965
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment with pyrazinamide given in increased doses twice a week in combination with other drugs].
    Pregowski W; Stańczuk-Holub A
    Gruzlica; 1973 Jul; 41(7):795-802. PubMed ID: 4730980
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
    Kaminskaia AA; Utkin VV; Korotaev GA; Golitsina LV
    Probl Tuberk; 1967; 45(5):29-33. PubMed ID: 5617941
    [No Abstract]   [Full Text] [Related]  

  • 31. [On therapeutic effects of morphazinamide, used alone and in association, in recent and chronic pulmonary tuberculosis].
    Pasargiklian M
    Minerva Med; 1965 Sep; 56(71):2855-62. PubMed ID: 5322267
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the intrapleural and intrabronchial administration of morphazinamide administered alone and in association with dexamethasone 21-orthophosphate].
    Oncina E
    Minerva Med; 1965 Sep; 56(70):2818-20. PubMed ID: 5852640
    [No Abstract]   [Full Text] [Related]  

  • 33. New TB drug approved.
    AIDS Patient Care; 1995 Feb; 9(1):42. PubMed ID: 11361363
    [No Abstract]   [Full Text] [Related]  

  • 34. [Level of blood serum level of uric acid in tuberculous patients treated with morphazinamide].
    Wawrzeńczyk B; Zaruski A
    Gruzlica; 1973 Feb; 41(2):177-80. PubMed ID: 4695789
    [No Abstract]   [Full Text] [Related]  

  • 35. Good news and not such good news.
    Iseman MD
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):87. PubMed ID: 10091871
    [No Abstract]   [Full Text] [Related]  

  • 36. [The present state of short course chemotherapy including pyrazinamide in Japan].
    Yamagishi F
    Nihon Kokyuki Gakkai Zasshi; 2004 Jun; 42(6):481-5. PubMed ID: 15228133
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the metabolism of morphazinamide in the treatment of chronic pulmonary tuberculosis].
    Zierski M; Gajewska E
    Gruzlica; 1965 Sep; 33(9):773-7. PubMed ID: 5859904
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pulmonary tuberculosis caused by Mycobacterium bovis with primary resistance to Isoniazide and pyrazinamide].
    Blanco Ramos JR; Rosel Rioja L; Dopereiro Gómez R; Oteo Revuelta JA
    An Med Interna; 1997 Aug; 14(8):433-4. PubMed ID: 9376493
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of pyrazinamide on the liver in patients with tuberculosis. An ultrastructural study].
    Pilheu JA; de Salvo MC; Arias RF; Koch OR
    Medicina (B Aires); 1985; 45(1):15-9. PubMed ID: 3880102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.